CYP2D6 and metabolic dysfunction-associated steatotic liver disease: However, higher CYP2C9 and CYP2D6 activity has most probably no significant role in NAFLD progression because these CYP isoforms do not produce ROS during their catalytic cycles, in contrast to CYP2E1 [18].